HC Wainwright Analysts Raise Earnings Estimates for ZNTL
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) – HC Wainwright upped their Q2 2025 earnings per share (EPS) estimates for shares of Zentalis Pharmaceuticals in a research note issued on Thursday, May 15th. HC Wainwright analyst A. Fein now expects that the company will post earnings per share of ($0.43) for the quarter, up from […]
